Doctoral Researcher, Centre for Science, Technology and Innovation Policy (CSTI), University of Cambridge

Martin is a doctoral researcher at the Centre for Science, Technology and Innovation Policy (CSTI) at Cambridge. He applies complexity science and systems engineering to derive quantitative evidence on research translation and challenge-led innovation, with a particular focus on the biomedical industry and DARPA model of innovation. One of his current studies explores the knowledge lineage of the mRNA vaccine platform and how government RD&D intervention substantiates such lineages. Theoretically, Martin is interested in finding the true clock of innovation, similar to the way in which returns on financial asset can be recovered through stochastic time change.

Martin’s role at Cambridge involves working with policymakers and scholars on the question of how best to organize innovation programs to achieve long-term commercial/societal outcomes, and contributed to projects such as Cambridge Industrial Innovation Policy’s roundtable on designing challenge-led innovation programs in UK, the Government Office for Science’s technology capability prioritization workshops, and Department for Business, Energy and Industrial Strategy’s international R&D prioritization framework. Martin began his career researching about genetic engineering and the human microbiome.